Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39,360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial.
Chen Y, Xu Y, Huang Y, Sun T, Hu Y, Xue F, Peng X, Lai Y, Zhou Z, Zhou H, Zhou R, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Li H, Liu X, Ma Y, Song Z, Peng J, Yang R, Zhang L. Chen Y, et al. Among authors: ma y. Am J Hematol. 2024 Jan;99(1):E22-E25. doi: 10.1002/ajh.27141. Epub 2023 Oct 26. Am J Hematol. 2024. PMID: 37883528 Clinical Trial. No abstract available.
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.
Chen Y, Xu Y, Chi Y, Sun T, Gao Y, Dou X, Han Z, Xue F, Li H, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Wang W, Ma Y, Song Z, Gu J, Gong W, Yang R, Zhang L. Chen Y, et al. Among authors: ma y. Signal Transduct Target Ther. 2024 Apr 23;9(1):102. doi: 10.1038/s41392-024-01793-5. Signal Transduct Target Ther. 2024. PMID: 38653983 Free PMC article. Clinical Trial.
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.
Liu W, Liu W, Zou H, Chen L, Huang W, Lv R, Xu Y, Liu H, Shi Y, Wang K, Wang Y, Xiong W, Deng S, Yi S, Sui W, Peng G, Ma Y, Wang H, Lv L, Wang J, Wei J, Qiu L, Zheng W, Zou D. Liu W, et al. Among authors: ma y. J Immunother Cancer. 2024 Apr 16;12(4):e008857. doi: 10.1136/jitc-2024-008857. J Immunother Cancer. 2024. PMID: 38631712 Free PMC article.
Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study.
Cao Y, Wang M, Wang F, Guo W, Ma Y, Li X, He Y, Pang A, Zhang R, Zhai W, Chen X, Ma Q, Wei J, Yang D, Huang Y, Feng D, Liu J, Gao X, Wen S, Wang W, Wang T, Li Y, Fang X, Li Y, Zhang X, Cai Y, Wang Y, Cao W, Lu R, Feng S, Guo R, Fu Y, Du X, Liu Z, Wang X, Wang L, Ma L, Liu C, Zhang X, Han M, Jiang E. Cao Y, et al. Among authors: ma l, ma q, ma y. Chin Med J (Engl). 2024 May 5;137(9):1115-1117. doi: 10.1097/CM9.0000000000002963. Epub 2024 Feb 2. Chin Med J (Engl). 2024. PMID: 38310445 Free PMC article. No abstract available.
A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis.
Yin J, Zhao M, Xu X, Zhang M, Xu Z, Li Z, Qin X, Li Z, Zhao C, Zhou H, Ma Y, Cao W, Wang G, Lin Y, Zhang J, Zhang X, Cai H, Qian W, Wang Y, Zhang X, Liu G, Wang J, Qiu W, Min L, Li J, Deng H, Chu L, Zhang Y, Fang J. Yin J, et al. Among authors: ma y. Eur J Neurol. 2024 May 10:e16322. doi: 10.1111/ene.16322. Online ahead of print. Eur J Neurol. 2024. PMID: 38726639
Ceria nanoparticles: biomedical applications and toxicity.
Fu X, Li P, Chen X, Ma Y, Wang R, Ji W, Gu J, Sheng B, Wang Y, Zhang Z. Fu X, et al. Among authors: ma y. J Zhejiang Univ Sci B. 2024 May 15;25(5):361-388. doi: 10.1631/jzus.B2300854. J Zhejiang Univ Sci B. 2024. PMID: 38725338 Review. Chinese, English.
39,360 results
You have reached the last available page of results. Please see the User Guide for more information.